Table 2.
Averages and Cohen’s d effect size for CEST contrasts in non-enhancing glioma patients (N = 18)
| NAWM | Tumour |
p-value Tumour vs NAWM |
Cohen’s d Tumour vs NAWM |
|
|---|---|---|---|---|
| B1 = 2.5 µT | ||||
| MTRasym | –0.006 ± 0.001 | –0.002 ± 0.004 | < 0.001* | 1.1 |
| LDamide | 0.012 ± 0.001 | 0.015 ± 0.002 | < 0.001* | 1.6 |
| LDNOE | 0.017 ± 0.002 | 0.019 ± 0.003 | 0.200 | 0.3 |
| B1 = 3.8 µT | ||||
| MTRasym | − 0.007 ± 0.002 | − 0.002 ± 0.006 | < 0.001* | 1.0 |
| LDamide | 0.018 ± 0.002 | 0.023 ± 0.003 | < 0.001* | 1.7 |
| LDNOE | 0.025 ± 0.002 | 0.027 ± 0.005 | 0.083 | 0.4 |
* NAWM and tumour value significantly different, p < 0.05, Bonferroni corrected